- Home
- AAME vs INMB Comparison
AAME vs INMB Comparison
Compare AAME & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAME
- INMB
- Stock Information
- Founded
- AAME 1968
- INMB 2015
- Country
- AAME United States
- INMB United States
- Employees
- AAME N/A
- INMB N/A
- Industry
- AAME Life Insurance
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- AAME Finance
- INMB Health Care
- Exchange
- AAME Nasdaq
- INMB Nasdaq
- Market Cap
- AAME 56.6M
- INMB 49.2M
- IPO Year
- AAME N/A
- INMB 2019
- Fundamental
- Price
- AAME $2.54
- INMB $1.69
- Analyst Decision
- AAME
- INMB Hold
- Analyst Count
- AAME 0
- INMB 3
- Target Price
- AAME N/A
- INMB $4.30
- AVG Volume (30 Days)
- AAME 26.5K
- INMB 380.0K
- Earning Date
- AAME 11-14-2025
- INMB 10-30-2025
- Dividend Yield
- AAME 0.79%
- INMB N/A
- EPS Growth
- AAME N/A
- INMB N/A
- EPS
- AAME 0.23
- INMB N/A
- Revenue
- AAME $208,218,000.00
- INMB $50,000.00
- Revenue This Year
- AAME N/A
- INMB $191.43
- Revenue Next Year
- AAME N/A
- INMB $12,299.51
- P/E Ratio
- AAME $10.87
- INMB N/A
- Revenue Growth
- AAME 11.99
- INMB 19.05
- 52 Week Low
- AAME $1.25
- INMB $1.38
- 52 Week High
- AAME $3.71
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- AAME 40.17
- INMB 52.07
- Support Level
- AAME $2.17
- INMB $1.46
- Resistance Level
- AAME $2.54
- INMB $1.62
- Average True Range (ATR)
- AAME 0.24
- INMB 0.10
- MACD
- AAME -0.03
- INMB 0.02
- Stochastic Oscillator
- AAME 35.48
- INMB 86.70
About AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.